Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Am J Hematol. 2015 Mar 2;90(4):320–326. doi: 10.1002/ajh.23937

Figure 1.

Figure 1

Figure 1A. EFS of AA patients who received IST and were diagnosed ≥2000, by disease subgroup (MAA/SAA, n=23; vSAA, n=8; p=0.08)

Figure 1B. OS of AA patients who received IST and were diagnosed ≥2000, by disease subgroup (MAA/SAA, n=23; vSAA, n=8; p=0.02)